Pricing Log in Create free account

ADMA Biologics Inc (ADMA) vs Telix Pharmaceuticals Limited (TLX)

ADMA Biologics Inc and Telix Pharmaceuticals Limited are both Biotechnology companies. ADMA Biologics Inc and Telix Pharmaceuticals Limited are of similar size ($3.2B and $3.0B). Across the 9 metrics below, ADMA Biologics Inc leads on 9 and Telix Pharmaceuticals Limited on 0.

Valuation

Metric ADMA TLX Biotechnology median
P/E 16.14 — 10.60
P/S 5.52 — 9.40
P/B 6.53 n/m 2.13
Price to free cash flow 21.59 n/m 25.18
EV/EBITDA 11.78 n/m 0.66
EV/Sales 5.66 n/m 9.02
Earnings yield 6.20% — (32.88%)
Free cash flow yield 4.63% 0.00% (23.13%)

Profitability

Metric ADMA TLX Biotechnology median
Gross margin 68.53% — 68.51%
Operating margin 46.47% — 0.00%
Net margin 35.14% — 0.00%
Free cash flow margin 25.54% 0.00% 0.00%
Return on equity 41.95% 0.00% (51.96%)
Return on assets 28.04% 0.00% (46.06%)
Return on invested capital 29.48% 0.00% 0.00%

Growth

Metric ADMA TLX Biotechnology median
Revenue growth (TTM) 6.26% — 6.76%
EPS growth (last fiscal year) (25.93%) (120.00%) 29.88%
Revenue growth, 5-year CAGR 64.60% — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ADMA TLX Biotechnology median
Debt to equity 0.45 1.18 0.00
Current ratio 6.04 2.01 4.97
Net debt to EBITDA (0.06) 6.25 1.01

Dividend

Metric ADMA TLX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ADMA TLX Biotechnology median
Market cap 2.96b 3.21b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack